Covid-19 | Subscribe

South Africa Maintains WHO Maturity
Level 3 (ML3) for Vaccine Regulation Find out more LATEST NEWS Angiotensin-Converting Enzyme Inhibitor-Induced
Angioedema: Risk of Serious and Fatal Outcomes Read more Safety Alert SAHPRA recalls certain batches of
Arya Enalapril 10mg used to treat
high blood pressure Find out more MEDIA RELEASE Regulations regarding Fees payable
in terms of the Provisions of the
Hazardous Substances Act Find Out More Document for Comment SAHPRA's Engagement Portal Visit the Portal E-Services View more E-Services Active Pharma Licenced
Establishments Find Out More Licences

E-library

Looking for a document – search here:

E-Services

Industry

Safety

Updates

News and Updates

In the Media

Stay updated with SAHPRA media coverage featuring expert insights on health regulations and medicine safety.

Databases and Registers

Active Pharma Licenced Establishments

Medical devices licences issued

PI & PIL Repository

Registered health products

Registered veterinary products

Online Medicine Directory

The Medicines’ Online Directory provides healthcare professionals and the consumer with a guide to all SAHPRA registered over-the counter (OTC) and prescription medicines that are available in South Africa.

Safety alerts

Whistleblower

The hotline has been established with the aim of enhancing an honest work ethic and simultaneously providing the public with a mechanism to bring any unethical business practices to the attention of management.

Product Recalls

SAHPRA enforces a recall when a product supplied in South Africa has a problem or potential problem. Enforcing a recall is the most effective way to protect the public from a potentially harmful medicine/medical product.

Events & Webinars

Stay up to date with upcoming, and past recorded events.

Social Media Feeds

Sahpra